{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:42:04Z","timestamp":1783528924317,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["APQ-0855-19"],"award-info":[{"award-number":["APQ-0855-19"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["315189\/2018-5"],"award-info":[{"award-number":["315189\/2018-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jpba.2022.114794","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:51:11Z","timestamp":1650862271000},"page":"114794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Development of the stability-indicating method, structural elucidation of new photodegradation products from terconazole by LC-MS TOF, and in vitro toxicity"],"prefix":"10.1016","volume":"216","author":[{"given":"Jos\u00e9 Wellithom Viturino","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Izak","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Xavier","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia Aparecida","family":"da Silva Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Kishishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lamartine Soares","family":"Sobrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Bastos","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whocely Victor","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davi Pereira de","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo C\u00e9sar Galindo","family":"Bedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.114794_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/mmy\/myv017","article-title":"A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis","volume":"53","author":"li","year":"2015","journal-title":"Med. Mycol. J."},{"issue":"8","key":"10.1016\/j.jpba.2022.114794_bib2","first-page":"525","article-title":"Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis","volume":"4","author":"Kjaeldgaard","year":"1986","journal-title":"Pharmacotherspy"},{"key":"10.1016\/j.jpba.2022.114794_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11046-008-9110-7","article-title":"Antifungal resistance mechanisms in dermatophytes","volume":"166","author":"Martinez-Rossi","year":"2008","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jpba.2022.114794_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultra deformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jpba.2022.114794_bib5","first-page":"67","article-title":"A review on stability studies of pharmaceutical products","volume":"2","author":"Narayan","year":"2017","journal-title":"IJAPBR"},{"key":"10.1016\/j.jpba.2022.114794_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.04.007","article-title":"Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: a comprehensive review","volume":"543","author":"Sengupta","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jpba.2022.114794_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0151-9638(06)70910-3","article-title":"Photosensibilisation au voriconazole: 7 cas","volume":"133","author":"Auffret","year":"2006","journal-title":"Ann. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jpba.2022.114794_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/tx800294z","article-title":"A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct","volume":"22","author":"Montanaro","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2022.114794_bib9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1039\/C3RA43644F","article-title":"Generation of reactive aryl radical intermediates in the reductive photodehalogenation of itraconazole","volume":"4","author":"Nardi","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2022.114794_bib10","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3390\/molecules15064129","article-title":"Conazoles","volume":"15","author":"Heeres","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2022.114794_bib11","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1039\/C8NJ00509E","article-title":"Development of a stability-indicating UPLC method for terconazole and characterization of the acidic and oxidative degradation products by UPLC-QTOF\/MS\/MS and NMR","volume":"42","author":"Chavan","year":"2018","journal-title":"New J. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2022.114794_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/pharmaceutics14030470","article-title":"Cyclodextrin stabilized freeze-dried silica\/chitosan nanoparticles for improved terconazole ocular bioavailability","volume":"14","author":"Zaghoul","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jpba.2022.114794_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2021.09.019","article-title":"Cationic polymeric nanoparticles for improved ocular delivery and antimycotic activity of terconazole","volume":"111","author":"Mohsen","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jpba.2022.114794_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.34172\/apb.2020.047","article-title":"Self-nanoemulsifying system optimization for higher terconazole solubilization and non-irritant ocular administration","volume":"10","author":"Yousry","year":"2020","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.jpba.2022.114794_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14756366.2017.1354858","article-title":"Analysis of imidazoles and triazoles in biological samples after micro extraction by packed sorbent","volume":"32","author":"Campestre","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jpba.2022.114794_bib16","unstructured":"International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Photostability Testing of New Active Substances and Medicinal Products Q1B, 1998. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-1-b-photostability-testing-new-active-substances-medicinal-products-step-5_en.DPf\u3009 (Accessed 17 March 2022)."},{"issue":"1","key":"10.1016\/j.jpba.2022.114794_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4172\/2157-7064.1000349","article-title":"Forced degradation study an essential approach to develop stability indicating method","volume":"8","author":"Sharma","year":"2017","journal-title":"J. Chromatogr. Sep Tech."},{"key":"10.1016\/j.jpba.2022.114794_bib18","series-title":"Martin\u2019s Physical Pharmacy and Pharmaceutical Sciences: Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences","author":"Sinko","year":"2006"},{"key":"10.1016\/j.jpba.2022.114794_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jscs.2012.12.001","article-title":"Quality by Design (QbD) approach to develop HPLC method for eberconazole nitrate: application oxidative and photolytic degradation kinetics","volume":"20","author":"Krishna","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.jpba.2022.114794_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2019.104181","article-title":"Stability study and oxidative degradation kinetics of posaconazole","volume":"151","author":"Ara\u00fajo","year":"2019","journal-title":"J. Microchem."},{"key":"10.1016\/j.jpba.2022.114794_bib21","unstructured":"OECD. Guidelines for the testing of chemicals. Test No. 437: Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants. Section 4: Health Effects, 2009. \u3008https:\/\/www.oecd-ilibrary.org\/environment\/test-no-437-bovine-corneal-opacity-and-permeability-test-method-for-identifying-i-chemicals-inducing-serious-eye-damage-and-ii-chemicals-not-requiring-classification-for-eye-irritation-or-serious-eye-damage_9789264203846-en\u3009 (Accessed 17 March 2022)."},{"key":"10.1016\/j.jpba.2022.114794_bib22","unstructured":"International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Photostability Testing of New Active Substances and Medicinal Products Q1A R2, 2003. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-1-r2-stability-testing-new-drug-substances-products-step-5_en.DPf\u3009 (Accessed 17 March 2022)."},{"key":"10.1016\/j.jpba.2022.114794_bib23","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1365\/s10337-009-1082-3","article-title":"LC stability studies of voriconazole and structural elucidation of its major degradation product","volume":"69","author":"Adams","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2022.114794_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.trac.2013.05.006","article-title":"Forced degradation studies to assess the stability of drugs and products","volume":"49","author":"Singh","year":"2013","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jpba.2022.114794_bib25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jpba.2008.09.005","article-title":"Validated stability indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium","volume":"48","author":"Ianchini","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.114794_bib26","series-title":"Photostability of Drugs and Drug Formulations","author":"Tonnesen","year":"2004"},{"key":"10.1016\/j.jpba.2022.114794_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/tx9800708","article-title":"Phototoxicity associated with diclofenac: a photophysical, photochemical, and photobiological study on the drug and its photoproducts","volume":"11","author":"Encinas","year":"1998","journal-title":"Chem. Res. Toxicol."},{"issue":"15","key":"10.1016\/j.jpba.2022.114794_bib28","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1021\/ol301694p","article-title":"Photoreactivity of fluoroquinolones: nature of aryl cations generated in water","volume":"14","author":"Soldevila","year":"2012","journal-title":"Org. Lett."},{"issue":"6","key":"10.1016\/j.jpba.2022.114794_bib29","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1017\/S0043174500083314","article-title":"Oxyfluorfen and lipid peroxidation: protein damage as a phytotoxic consequence","volume":"33","author":"Kunert","year":"1985","journal-title":"Weed Sci."},{"issue":"1","key":"10.1016\/j.jpba.2022.114794_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2009.05.019","article-title":"A proposed eye irritation testing strategy to reduce and replace in vivo studies using bottom\u2013up and top\u2013down approaches","volume":"24","author":"Scott","year":"2010","journal-title":"Toxicol. Vitr."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522002151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522002151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:06:27Z","timestamp":1777572387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522002151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"alternative-id":["S0731708522002151"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114794","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of the stability-indicating method, structural elucidation of new photodegradation products from terconazole by LC-MS TOF, and in vitro toxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114794"}}